Cite
HARVARD Citation
Bamias, A. et al. (2023). Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm. Anti-cancer drugs. 34 (3), pp. 413-421. [Online].